The Lupus Foundation of America, Lone Star Chapter does not endorse the physicians listed below. This is a referral list only. This is NOT a comprehensive list; we urge all patients to confirm their insurance information with the physician’s office before making an appointment.

The Lupus Foundation of America, Lone Star Chapter does not endorse any of the programs or organizations published herein, but present them for your information. We oppose self-diagnosis and self-treatment. We urge all that read this publication to discuss any concerns they may have about diagnosis and/or treatments with their physician.

Clinical Trials

LFA Center for Clinical Trials Education

The LFA has established the Center for Clinical Trials Education (CCTE) to provide information for anyone who may be interested in participating in a clinical trial of a potential new treatment for lupus. The website includes a search function that allows trials to be identified in specific geographic areas. Click here for more information.

Lupus Trials Listed on ClinicalTrials.gov

ClinicalTrials.gov provides regularly updated information about federally and privately supported clinical research. ClinicalTrials.gov provides information about clinical trials and their purpose, as well as information about who may participate, study locations, and contact information for more details.Click here for more information.

Dallas Clinical Trials

Two studies are being conducted by UT Southwestern Medical Center, Rheumatology Department. Celgene and SMILE.

MCRC Clinical Research Study

A clinical research study is under way to evaluate a new investigational drug for people living with Systemic Lupus Erythematosus (SLE) every day. SLE is the most common type of lupus, which mainly strikes young women of African, Hispanic, and Asian descent. If you have SLE, you may be eligible to participate in this important clinical research study. You may qualify to participate if you:

Are between the ages of 18 and 70

Have been diagnosed with lupus ≥ 24 weeks

Qualified participants will receive study related medication and care at no cost. Other eligibility criteria will apply and insurance is not required. You will be asked to complete up to 16 clinic visits over a 64 week period. Compensation for time and travel may be provided if you qualify for the study.

To find out more about this clinical research study please contact MCRC at 214-424-0405.